Haoxi Health Technology Ltd
Datakwaliteit: 100%
HAO
Nasdaq
Services
Business Services
€ 1,07
▼
€ 0,04
(-3,60%)
Marktkapitalisatie: 65,98 M
Prijs
€ 1,11
Marktkapitalisatie
65,98 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Earnings grew 200,13% over the past year
ROE of 27,06% indicates high profitability
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -3,41 M
Capital efficient — spends only 0,17% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-32,39%
Earnings (1Y)200,13%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
27,06%
Boven sectorgemiddelde (-15,74%)
ROIC-11,87%
Net Margin11,82%
Op. Margin-6,10%
Veiligheid
Debt / Equity
0,08
Onder sectorgemiddelde (0,39)
Current Ratio6,02
Interest Coverage-43,52
Waardering
PE (TTM)
17,02
Boven sectorgemiddelde (-1,17)
P/B Ratio3,52
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 17,0 | -1,2 |
| P/B | 3,5 | 1,4 |
| ROE % | 27,1 | -15,7 |
| Net Margin % | 11,8 | -18,3 |
| Rev Growth 5Y % | — | 3,8 |
| D/E | 0,1 | 0,4 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -32,39% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 200,13% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 32,80 M | Net Income (TTM) | 3,88 M |
| ROE | 27,06% | ROA | 20,90% |
| Gross Margin | 2,83% | Operating Margin | -6,10% |
| Net Margin | 11,82% | Free Cash Flow (TTM) | -3,41 M |
| ROIC | -11,87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 6,02 |
| Interest Coverage | -43,52 | Asset Turnover | 1,77 |
| Working Capital | 16,53 M | Tangible Book Value | 16,73 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 17,02 | Forward P/E | N/A |
| P/B Ratio | 3,52 | P/S Ratio | 2,01 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5,17% | ||
| Market Cap | 65,98 M | Enterprise Value | 67,41 M |
| Per Share | |||
| EPS (Diluted TTM) | 1,32 | Revenue / Share | 0,55 |
| FCF / Share | -0,06 | OCF / Share | -0,06 |
| EPS CAGR (1Y) | 3200,00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,17% | FCF Conversion | -88,05% |
| SBC-Adj. FCF | -3,47 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 32,80 M | 48,52 M |
| Net Income | 3,88 M | 1,29 M |
| EPS (Diluted) | 1,32 | 0,04 |
| Gross Profit | 927.750,0 | 2,75 M |
| Operating Income | -2,00 M | 1,72 M |
| EBITDA | — | — |
| R&D Expenses | 79.544,0 | 79.985,0 |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 45.956,0 | 41.186,0 |
| Income Tax | 270.744,0 | 443.582,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 21,60 M | 15,51 M |
| Total Liabilities | 4,22 M | 4,23 M |
| Shareholders' Equity | 17,38 M | 11,27 M |
| Total Debt | 1,61 M | 1,14 M |
| Cash & Equivalents | — | 6,66 M |
| Current Assets | 19,60 M | 15,38 M |
| Current Liabilities | 3,89 M | 3,87 M |
{"event":"ticker_viewed","properties":{"ticker":"HAO","listing_kind":"stock","pathname":"/stocks/hao","exchange":"Nasdaq","country":"US"}}